RResearch Square5d agoFAM111B, LAG3, and FGL1, A Three-Gene Signature as a Predictive Biomarker for Immunotherapy Response in Bladder Urothelial CarcinomaWanying Li·Lihong Zhang·Fang Wei·Wenlong Wan·Huihua XiongRead at Research SquareShareLess like thisTagsBladder and Urothelial Cancer TreatmentsSurgery
